Health Catalyst (HCAT) Reports In-Line Q1 EPS

Health Catalyst (NASDAQ: HCAT) reported Q1 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $70.76 million versus the consensus estimate of $69.75 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
• Ford CEO Says Transportation Secretary Had 'Basic Misunderstandings' in Letter - WSJ
• American Eagle Outfitters (AEO) Tops Q2 EPS by 57c